Muscle Degeneration: Types, Causes, Symptoms, and Management
Muscle degeneration encompasses disorders with progressive loss of muscle structure and function. Terms: muscular dystrophy (genetic), myopathy (acquired/genetic muscle disease), sarcopenia (age-related).
Major Categories and Examples
1. Genetic Muscular Dystrophies
- Duchenne (DMD): X-linked, DMD gene (dystrophin). Onset 3–5 years; wheelchair by teens; cardiomyopathy, respiratory failure. Life expectancy ~30 with modern care.
- Becker (BMD): Milder, later onset, some functional dystrophin.
- Myotonic dystrophy type 1 (DM1): DMPK CTG repeat; multisystem (myotonia, cataracts, endocrine, cardiac).
- Limb-girdle (LGMD): >30 subtypes; proximal weakness; variable severity.
- Facioscapulohumeral (FSHD): DUX4 dysregulation; face, scapula, humeral weakness.
2. Acquired Myopathies
- Inflammatory: Dermatomyositis (skin + proximal weakness), polymyositis, inclusion body myositis (IBM — elderly, asymmetric, quadriceps/finger flexors), immune-mediated necrotizing myopathy (IMNM).
- Endocrine: Thyroid (hyper/hypo), steroid myopathy, vitamin D deficiency.
- Toxic/Drug-induced: Statins, colchicine, chloroquine, alcohol.
- Critical illness myopathy: ICU-acquired, sepsis, neuromuscular blockade, corticosteroids → diffuse weakness.
3. Neuromuscular Junction Disorders
- Myasthenia gravis: Anti-AChR/MuSK antibodies → fatigable weakness (ocular, bulbar, limb).
- Lambert-Eaton (LEMS): Anti-VGCC; proximal weakness improves with exercise.
4. Age-Related: Sarcopenia
- Loss of mass, strength, function. Starts ~40s; accelerates >65.
- Drivers: anabolic resistance, inflammation, denervation, mitochondrial dysfunction, inactivity.
- Consequences: frailty, falls, fractures, mortality, loss of independence.
Common Symptoms
- Progressive weakness (proximal > distal typically).
- Fatigue, exercise intolerance.
- Muscle atrophy, fasciculations (if neurogenic).
- Falls, gait difficulty, trouble rising from chair (Gowers' sign in DMD).
- Dysphagia, respiratory insufficiency (late).
Diagnostic Approach
- CK (markedly elevated in dystrophies, IMNM; normal in IBM, MG).
- EMG/NCS (myopathic vs. neurogenic).
- Muscle MRI (pattern recognition).
- Genetic testing (panel, WES/WGS).
- Muscle biopsy (if genetic negative or inflammatory suspected).
- Autoantibodies (myositis panel, AChR, MuSK).
Management Principles
- Genetic: Corticosteroids (deflazacort, prednisone) for DMD; exon-skipping (eteplirsen), gene therapy (delandistrogene moxeparvovec). Multidisciplinary clinics.
- Inflammatory: Immunosuppression (steroids, IVIG, rituximab, mycophenolate).
- MG: Pyridostigmine, thymectomy, immunosuppression, complement inhibitors (eculizumab, ravulizumab).
- Sarcopenia: Resistance training (mandatory), protein 1.2–1.5 g/kg, vitamin D, treat comorbidities.
- Supportive: PT/OT, orthotics, respiratory support, cardiac monitoring, nutrition, psychosocial.
Early specialist referral (neuromuscular neurologist) improves outcomes.
Muscle Strains - Related Articles
- Nerve Injury Treatments: Understanding Options and Recovery
- Cardiac Muscle: Why It's Involuntary, Not Voluntary
- Type IIA Muscle Fibers: The Fast-Twitch Oxidative Powerhouses
- Strength Training at Any Age: Benefits for Seniors and Beginner Guidelines
- Breathing Muscles: Diaphragm, Intercostals & Accessory Muscles in Exercise
- Acetylcholine Receptor Binding at the Neuromuscular Junction
- Mineral Soaks for Leg Cramps: Relief & Prevention
